Similar articles

• Differential levels of synovial fluid aggrecan aggregate components in experimental osteoarthritis and joint disuse.

  Ratcliffe A, Beauvais PJ, Saed-Nejad F. Ratcliffe A, et al. J Orthop Res. 1994 Jul;12(4):464-73. doi: 10.1002/jor.1100120403. J Orthop Res. 1994. PMID: 7520485
• Aggrecan degradation in osteoarthritis and rheumatoid arthritis.

  Lark MW, Bayne EK, Lohmander LS. Lark MW, et al. Acta Orthop Scand Suppl. 1995 Oct;266:92-7. Acta Orthop Scand Suppl. 1995. PMID: 8553869 Review. No abstract available.
• The release of aggrecan fragments into synovial fluid after joint injury and in osteoarthritis.

  Lohmander LS. Lohmander LS. J Rheumatol Suppl. 1995 Feb;43:75-7. J Rheumatol Suppl. 1995. PMID: 7752145
• Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.

  Manicourt DH, Poilvache P, Van Egeren A, Devogelaer JP, Lenz ME, Thonar EJ. Manicourt DH, et al. Arthritis Rheum. 2000 Feb;43(2):281-8. doi: 10.1002/1529-0131(200002)43:2<281::AID-ANR7>3.0.CO;2-7. Arthritis Rheum. 2000. PMID: 10693867
• Changes in chondroitin sulphate structure induced by joint disease.

  Hardingham T. Hardingham T. Acta Orthop Scand Suppl. 1995 Oct;266:107-10. Acta Orthop Scand Suppl. 1995. PMID: 8553837 Review. No abstract available.